Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-initiated therapy versus 5-day episodic treatment for recurrent herpes simplex
jRCT1031230671Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of famciclovir in herpes simplex (HSV), sponsored by Maruho Co., Ltd. Started Feb 2024; status: completed.
02
Drugs
famciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on jRCT1031230671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230671.